Skip to main content

2 Result(s)

within M Zola Remove this filter

and

  1. Article

    Open Access

    Lipocalin 2 as a potential systemic biomarker for central serous chorioretinopathy

    No systemic biomarker of Central Serous Chorioretinopathy (CSCR) has been identified. Lipocalin 2 (LCN2 or NGAL), alone or complexed with MMP-9 (NGAL/MMP-9), is increased in several retinal disorders. Serum le...

    A. Matet, T. Jaworski, E. Bousquet, J. Canonica, C. Gobeaux… in Scientific Reports (2020)

    Download PDF (1137 KB) View Article

  2. Article

    Identification of time point to best define ‘sub-optimal response’ following intravitreal ranibizumab therapy for diabetic macular edema based on real-life data

    To determine the average time-point at which it is best to define ‘sub-optimal response’ after ranibizumab treatment for diabetic macular edema (DME) based on the data obtained from real-life clinical practice.

    I Chatziralli, M Santarelli, N Patrao, L Nicholson, M Zola, R Rajendram, P Hykin… in Eye (2017)

    Download PDF (153 KB) View Article